Meitar represented Covidien, a U.S. medical device manufacturer, in its acquisition of Oridion Systems Ltd., an Israeli company and a global leader in capnography monitoring, for $346 million in cash. The transaction is expected to be completed during the second quarter of 2012.
Meitar represented Broadlight a provider of highly integrated networking and fiber access PON (Passive Optical Network) processors in its acquisition by Broadcom Corporation a global leader in semiconductor solutions for wired and wireless communications for approximately $220 million. The transaction was completed on April 5, 2012.
Our firm, together with US-based Fenwick & West LLP, represented Facebook, Inc. (NASDAQ: FB) in the acquisition of Face.com, the developer of a leading face-recognition technology. Financial terms of the transaction were not disclosed.
Meitar represented privately-held Surpass Medical Ltd., a developer of next-generation flow diversion stent technology to treat brain aneurysms using a unique mesh design and delivery system in its acquisition by Stryker Corporation for up to $135 million, in an all cash transaction.
As part of the transaction, the controlling shareholder purchased the shares of Hot, Israel’s leading cable television company, held by the public in a reverse triangular merger. The controlling shareholder financed the purchase through the issuance of bonds to a syndicate of international banks. These transactions were the last part of the establishment of a leading telecom group in Israel, after purchasing the cellular carrier HOT Mobile (formerly Mirs) from Motorola, and gradually increasing the holdings of the controlling shareholders in HOT over the last three years. The total transaction value, including other share purchases by the controlling shareholder, was $1.1 billion.
The full update (in Hebrew) is available through the PDF icon.
Antitrust / Competition Law
Technology and Intellectual Property 
